Stay updated with breaking news from Prevention Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A decade ago, Exact Sciences launched Cologuard, impacting the fight against colorectal cancer. Its growth of 7000% is in part due to a focus on consumerization.
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The
/PRNewswire/ -- The "Rare Disease Genetic Testing Market - A Global and Regional Analysis: Focus on Disease Type, Offering, Specialty Type, Sample Type, Trait...
Major players in the whole exome sequencing market are Thermo Fisher Scientific Inc., Illumina Inc., Eurofins Genomics, Azenta US Inc., CD Genomics,...
Exact Sciences demonstrated exceptional financial discipline during Q3, delivering robust growth with lower operating expenditure. See why I rate EXAS a Buy.